The University of Maryland School of Pharmacy offers an ASHP-accredited two-year PGY1/PGY2 Residency in Pharmacotherapy. The purpose of this program is to train clinical pharmacists to have a strong foundation of clinical, teaching, and research skills, which will allow them to practice independently in a wide variety of institutional environments. Upon completion of the 24 month Pharmacotherapy Residency, residents will be well-equipped to obtain a position in academia or as a clinical specialist.
Core rotations will include internal medicine, critical care, research, cardiology, infectious diseases, management, pediatrics, oncology, transplantation, and ambulatory care experiences. Multiple elective rotations will also be offered. Residents will also be given the opportunity to develop their teaching and research skills. If desired, the program can be designed to allow the resident to select an area of practice in which he or she wishes to focus.
As part of its accreditation by the American Society of Health-System Pharmacists (ASHP), this program is committed to the following general purpose:
Postgraduate Year 2 (PGY2) pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and Postgraduate Year 1 (PGY1) pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).
Because this residency program is accredited by ASHP, the resident will complete the following ASHP-established outcomes:
|Competency Area R1: Patient Care||Goal R1.1: In collaboration with the health care team, provide comprehensive medication management to patients with cardiovascular diseases following a consistent patient care process.
Goal R1.2: Ensure continuity of care during patient transitions between care settings.
Goal R1.3: Prepare, dispense, and manage medications to support safe and effective drug therapy for patients.
|Competency Area R2: Advancing Practice and Improving Patient Care||Goal R2.1: Demonstrate ability to manage formulary and medication-use processes, as applicable to the organization.
Goal R2.2: Demonstrate ability to evaluate and investigate practice, review data, and assimilate scientific evidence to improve patient care and/or the medication use system (PGY1).
Goal R2.3: Demonstrate ability to conduct a quality improvement or research project (PGY2 ONLY).
|Competency Area R3: Leadership and Management||Goal R3.1: Demonstrate leadership skills for successful self-development.
Goal R3.2: Demonstrate management skills.
|Competency Area R4: Teaching, Education, and Dissemination of Knowledge||Goal R4.1: Provide effective medication and practice-related education to patients, caregivers, health care professionals, students, and the public (individuals and groups).
Goal R4.2: Effectively employ appropriate preceptor roles when engaged in teaching students, pharmacy technicians, or fellow health care professionals in cardiovascular diseases.
|Competency Area R5: Management of Medical Emergencies||Goal R5.1: Demonstrate understanding of the management of medical emergencies.|
|Competency Area E1: Academia||Goal E1.1: Demonstrate understanding of key elements of the academic environment and faculty roles within it.
Goal E1.2: Exercise case-based and other teaching skills essential to pharmacy faculty.
Goal E1.3: Develops and practices a philosophy of teaching.
|Competency Area E2: Additional Contributions Pharmacotherapy Knowledge||Goal E2.1: Prepare and deliver effective poster presentations.
Goal E2.2: Conduct effective peer review of materials for publication or presentation.
|Competency Area E3: Medication-Use Evaluations||Goal E3.1: Lead medication-use evaluations.|
|Competency Area E4: Added Leadership and Practice Management Skills||Goal E4.1: Apply leadership and practice management skills to contribute to management of pharmacy services.
Goal E4.2: Contribute to the management and development of pharmacy staff.
Goal E4.3: Understand the process of establishing a pharmacy residency program.
|Competency Area E5: Specialty Pharmacy||Goal E5.1: Effectively fulfill the major functions of a specialty pharmacist, including intake, clinical management, fulfillment, and facilitating optimal outcomes.|
|Competency Area E6: Health, Wellness, and Emergency Preparedness||Goal E6.1: Design and deliver programs that contribute to public health efforts.|
Additionally, our program adheres to the required Goals and Objectives for a Postgraduate Year One (PGY1) Pharmacy Residencies and the required Goals and Objectives for Postgraduate Year Two (PGY2) Pharmacotherapy Residencies set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.
- Develop individuals with a strong foundation of skills and knowledge to practice as a clinical pharmacist caring for a wide variety of patients in an institutional environment.
- Allow individuals to practice as an independent practitioners working with other healthcare providers to provide optimal medication therapy in a wide variety of institutional patient care areas.
- Demonstrate proficiency in teaching and scholarly activity and the development of these skills.
- Prepare the resident to attain board certification as a pharmacotherapy specialist.
Rotations will take place at the University of Maryland Medical Center (UMMC) and Baltimore Veterans Affairs Hospital.
Required Rotations: Adult Internal Medicine, Intensive Care Unit, Cardiology, Infectious Diseases, Pediatrics, Oncology, Transplant, Research, Management, and Longitudinal Ambulatory Care Rotations over 24 months.
Elective Rotations (Up to 4): Multiple Intensive Care Units, Toxicology, Emergency Medicine.
In addition to these unique experiences, the pharmacotherapy resident is expected to participate in Pharmacotherapy Rounds, the Professional Development Seminar Series, School of Pharmacy teaching activities, Case Conferences, and Journal Club. For more information about these specific activities, please click here.
Qualifications: The resident must be a graduate of an accredited college of pharmacy with a minimum GPA of 3.0 (requirement waived if completed a pass/fail curriculum). The Doctor of Pharmacy (PharmD) degree and Maryland Pharmacy licensure are required.
Applications for this program will only be accepted through PhORCAS.
In addition to the standard reference template in PhORCAS, three letters of recommendation are required. These should be uploaded in PhORCAS by the reference writer.
The application deadline is January 1.
International students and permanent residents should contact email@example.com before applying.
Residents who match to this program will be required to come to Baltimore in advance of the July 1st start date for campus orientation; these orientation dates are not known until mid-Spring. These sessions are typically offered on select Mondays in May and June.
Asha L. Tata, PharmD, BCPS
Internal Medicine Clinical Pharmacist
Clinical Associate Professor, University of Maryland School of Pharmacy
University of Maryland Medical Center Department of Pharmacy Services
29 South Greene Street, Suite 400
Baltimore, MD 21201
Mojdeh S. Heavner, PharmD, BCPS, BCCCP
Associate Professor, Critical Care
University of Maryland School of Pharmacy
20 North Pine Street, Rooms N427
Baltimore, MD 21201